Misonix files 510(k) for ultrasonic wound debrider

Ultrasound developer Misonix of Farmingdale, NY, has filed a 510(k) application with the Food and Drug Administration (FDA) for clearance to market its ultrasonic wound debridement system.

The firm said that in clinical trials in Italy and the U.S. the device performed wound debridement with less bleeding than current debridement methods, and appears to aid in the promotion of rapid healing. The product already has approval through a previous filing of a 510(k) application pertaining to soft-tissue aspiration, Misonix said.

By AuntMinnie.com staff writers
April 21, 2005

Related Reading

Misonix adds to executive ranks, September 28, 2004

Misonix expands into Latin America, April 13, 2004

Misonix brings Sonablate to Europe, March 31, 2004

Misonix to distribute Sonablate 500 in Europe, March 2, 2004

Misonix continues gains in Q2, January 29, 2004

Copyright © 2005 AuntMinnie.com

Page 1 of 509
Next Page